Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery

Colorectal Disease

Volumn 18, Issue 2, 2016, Pages 163-172

  Ding, Z ^a   Wu, X R ^a   Remer, E M ^a   Lian, L ^a   Stocchi, L ^a   Li, Y ^a   Mccullough, A ^a   Remzi, F H ^a   Shen, B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Body mass index; Crohn's disease; Postoperative complications; Primary surgery; Visceral fat area; Visceral obesity

Indexed keywords

CORTICOSTEROID;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVERSION TO OPEN SURGERY; CROHN DISEASE; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; ILEUS; INTESTINE PARAMETERS; INTESTINE RESECTION; INTESTINE RESECTION LENGTH; INTESTINE SURGERY; INTRAABDOMINAL FAT; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SUBCUTANEOUS FAT; VISCERAL FAT AREA; COLONOSCOPY; COMPLICATION; DIAGNOSTIC IMAGING; INTESTINAL DISEASES; MIDDLE AGED; ODDS RATIO; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; X-RAY COMPUTED TOMOGRAPHY;

ADULT; BLOOD LOSS, SURGICAL; COLONOSCOPY; CROHN DISEASE; FEMALE; HUMANS; ILEUS; INTESTINAL DISEASES; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; ODDS RATIO; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84970937997     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.13128     Document Type: Article

References (48)

1. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012; 380: 1590-605.
2. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-94.
3. Buisson A, Chevaux JB, Allen PB, Bommelaer G, Peyrin-Biroulet L. Review article: the natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther 2012; 35: 625-33.
4. Hashash JG, Regueiro MD. The evolving management of postoperative Crohn's disease. Expert Rev Gastroenterol Hepatol 2012; 6: 637-48.
5. Shiraki M, Yamamoto T. The impact of preoperative use of infliximab on postoperative complications in patients with Crohn's disease. J Crohns Colitis 2012; 6: 1038.
6. Jacobson S. Early postoperative complications in patients with Crohn's disease given and not given preoperative total parenteral nutrition. Scand J Gastroenterol 2012; 47: 170-7.
7. Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007; 50: 331-6.
8. Syed A, Cross RK, Flasar MH. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients. Am J Gastroenterol 2013; 108: 583-93.
9. Li Y, Lopez R, Queener E, Shen B. Adalimumab therapy in Crohn's disease of the ileal pouch. Inflamm Bowel Dis 2012; 18: 2232-9.
10. Appau KA, Fazio VW, Shen B et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg 2008; 12: 1738-44.
11. Tzivanakis A, Singh JC, Guy RJ, Travis SP, Mortensen NJ, George BD. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery. Dis Colon Rectum 2012; 55: 558-62.
12. Yamamoto S, Watabe K, Takehara T. Is obesity a new risk factor for gastritis? Digestion 2012; 85: 108-10.
13. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-41.
14. Long MD, Crandall WV, Leibowitz IH et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 2162-8.
15. Causey MW, Johnson EK, Miller S, Martin M, Maykel J, Steele SR. The impact of obesity on outcomes following major surgery for Crohn's disease: an American College of Surgeons National Surgical Quality Improvement Program assessment. Dis Colon Rectum 2011; 54: 1488-95.
16. Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, Cosnes J. Crohn's disease clinical course and severity in obese patients. Clin Nutr 2002; 21: 51-7.
17. Valentijn TM, Galal W, Hoeks SE, van Gestel YR, Verhagen HJ, Stolker RJ. Impact of obesity on postoperative and long-term outcomes in a general surgery population: a retrospective cohort study. World J Surg 2013; 37: 2561-8.
18. Al-Refaie WB, Parsons HM, Henderson WG et al. Body mass index and major cancer surgery outcomes: lack of association or need for alternative measurements of obesity? Ann Surg Oncol 2010; 17: 2264-73.
19. Velludo CM, Kamimura MA, Sanches FM et al. Prospective evaluation of waist circumference and visceral adipose tissue in patients with chronic kidney disease. Am J Nephrol 2010; 31: 104-9.
20. Moore LL, Bradlee ML, Singer MR et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord 2004; 28: 559-67.
21. Bertin B, Desreumaux P, Dubuquoy L. Obesity, visceral fat and Crohn's disease. Curr Opin Clin Nutr Metab Care 2010; 13: 574-80.
22. Gradmark AM, Rydh A, Renstrom F et al. Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry. Br J Nutr 2010; 104: 582-8.
23. Kullberg J, Brandberg J, Angelhed JE et al. Whole-body adipose tissue analysis: comparison of MRI, CT and dual energy X-ray absorptiometry. Br J Radiol 2009; 82: 123-30.
24. Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 2012; 85: 1-10.
25. Tsujinaka S, Konishi F, Kawamura YJ et al. Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum 2008; 51: 1757-65; discussion 1765-7.
26. Hagiwara M, Miyajima A, Hasegawa M et al. Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy. BJU Int 2012; 110: E980-4.
27. Shimizu A, Tani M, Kawai M et al. Influence of visceral obesity for postoperative pulmonary complications after pancreaticoduodenectomy. J Gastrointest Surg 2011; 15: 1401-10.
28. Erhayiem B, Dhingsa R, Hawkey CJ, Subramanian V. Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's disease. Clin Gastroenterol Hepatol 2011; 9: 684-7.e1.
29. Ferrante M, D'Hoore A, Vermeire S et al. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1062-70.
30. Yoshizumi T, Nakamura T, Yamane M et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283-6.
31. Shen W, Punyanitya M, Chen J et al. Visceral adipose tissue: relationships between single slice areas at different locations and obesity-related health risks. Int J Obes (Lond) 2007; 31: 763-9.
32. Shen W, Punyanitya M, Wang Z et al. Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr 2004; 80: 271-8.
33. Demerath EW, Shen W, Lee M et al. Approximation of total visceral adipose tissue with a single magnetic resonance image. Am J Clin Nutr 2007; 85: 362-8.
34. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13.
35. Gu J, Stocchi L, Geisler DP, Kiran RP. Staged restorative proctocolectomy: laparoscopic or open completion proctectomy after laparoscopic subtotal colectomy? Surg Endosc 2011; 25: 3294-9.
36. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000; 231: 38-45.
37. Poonawalla AH, Sjoberg BP, Rehm JL et al. Adipose tissue MRI for quantitative measurement of central obesity. J Magn Reson Imaging 2013; 37: 707-16.
38. Vlachos IS, Hatziioannou A, Perelas A, Perrea DN. Sonographic assessment of regional adiposity. AJR Am J Roentgenol 2007; 189: 1545-53.
39. Micklesfield LK, Goedecke JH, Punyanitya M, Wilson KE, Kelly TL. Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat. Obesity (Silver Spring) 2012; 20: 1109-14.
40. Hunter GR, Snyder SW, Kekes-Szabo T, Nicholson C, Berland L. Intra-abdominal adipose tissue values associated with risk of possessing elevated blood lipids and blood pressure. Obes Res 1994; 2: 563-8.
41. Despres JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1993; 6: 137-59.
42. Li Y, Zhu W, Gong J et al. Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease. Colorectal Dis 2015; 17: 225-34.
43. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-7.
44. Peyrin-Biroulet L, Chamaillard M, Gonzalez F et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut 2007; 56: 577-83.
45. Paul G, Schaffler A, Neumeier M et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 2006; 12: 471-7.
46. Batra A, Zeitz M, Siegmund B. Adipokine signaling in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 1897-905.
47. Katznelson L, Fairfield WP, Zeizafoun N et al. Effects of growth hormone secretion on body composition in patients with Crohn's disease. J Clin Endocrinol Metab 2003; 88: 5468-72.
48. Desreumaux P, Ernst O, Geboes K et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999; 117: 73-81.